COVID-19 Preclinical Discovery Awards
Paul Auwaerter and Mark Sulkowski, both professors in the Division of Infectious Diseases, are the therapeutics team leaders for the university’s COVID-19 Research Response Program.
In response to the COVID-19 pandemic, Johns Hopkins University has funded the COVID-19 Pre-clinical Research Discovery Fund (C19PcRDF), which has awarded four grants of up to $50,000 each. These awards are meant to stimulate innovative research that may lead to further translational or clinical efforts. Under the leadership of the COVID Therapeutics Team, applications were received from 46 investigators across the university, resulting in a highly competitive review. The following four proposals were selected.
| PI | School | Department | Project Title |
| Anthony K. L. Leung, Ph.D. | Public Health | Biochemistry & Molecular Biology | Developing macrodomain inhibitor for the treatment of COVID19 and other coronavirus infections |
| Susan Michaelis, Ph.D. | Medicine | Cell Biology | Mechanism of Protection from Viral Infection by the Integral Membrane Zinc Metalloprotease ZMPSTE24 |
| Linda Resar, M.D. | Medicine | Medicine, Hematology | HMGA1-NF-KB Complexes in COVID19-induced Inflammatory Lung Disease |
| Maxim Rosario, M.D., Ph.D. | Medicine | Pathology | Pre-clinical design and testing of a T cell-mediated vaccine for COVID-19 |
COVID-19 Launchpad Awards
The Johns Hopkins Alliance for a Healthier World has given health equity-focused COVID-19 grants to researchers, policy experts and program implementers at Johns Hopkins University. The recipients at the School of Medicine and their research proposals are:
- Lisa Cooper, professor in the Division of General Internal Medicine: Tired Heroes without Capes: Supporting Frontline Healthcare Workers in the Face and Aftermath of COVID-19
- Anne Burke and Carolyn Sufrin: Mitigating the Health Equity Impacts of COVID-19 on Abortion Access through Advocacy
- Che Harris: Examination of Medical Mistrust and Misinformation of COVID-19 among Low Income African-Americans with Comorbid Risk Factors
- Megan Collins and Sara Johnson: The K-12 School Health Equity Project: Examining School Closures, Health Outcomes and Learning
- Arik Marcell: Delivering a Telehealth-Supported Digital Toolkit to Baltimore City’s Approved Family Child Care Home Providers Caring for Children of Essential Workers)
- Maya Venkataramani, assistant professor in the Division of General Internl Medicine: The Social and Economic Consequences of the COVID-19 Pandemic Among People Living with HIV in Kenya
- Gregory Lucas and Kathleen Page, professor and associate professor in the Division of Infectious Diseases: Improving Access to and Use of Harm Reduction and Healthcare Services among People Who Inject Drugs Living in Low Income Communities During the COVID-19 Pandemic
- Sara Johnson, Raquel Hernandez and Rachel Thornton: Characterizing the Social, Economic, and Health Impact of COVID-19 on Vulnerable Families
- Nadia Hansel and Nirupama Putcha, professor and assistant professor in the Division of Pulmonary: Air Pollution and COPD Hospitalizations in Baltimore in the Context of COVID-19
- Seun Falade, assistant professor in the Division of Infectious Diseases: The Impact of COVID-19 on People Who Use Drugs
- Meredith McCormack and Michelle Eakin, associate professors in the Division of Pulmonary, and Emily Brigham, assistant professor in Pulmonary: The Impact of the Physical and Psychosocial Environment and COVID-19 Among Children with Asthma Living in Low Income, Urban Neighborhoods
- Monica Guerrero Vázquez and Kathleen Page: RAPID-Baltimore: A Mobile Application for Rapid Access to Infectious Disease Information for Baltimore
